Skip to content
← Lobby register
ES
NGO

European Society for Paediatric Oncology

🇪🇺 BELGIUMRegistered 13/012 staff
Disclosed budget
€1,377,071
Meetings 12mo
7
Policy files
0
Accredited passes
1

Recent meetings

DateCommissioner / CabinetTopicFile
19 Sept 2025
Ann-Sofie Ronnlund
Cabinet member
Childhood cancerSRC
19 Sept 2025
Ekaterina Zaharieva
Commissioner
Childhood cancerSRC
19 Sept 2025
Ekaterina Zaharieva
Commissioner
Childhood cancer
20 Jun 2025
Maya Matthews
Head of Unit
Discussion on the identification of clinical experts to participate in joint scientific consultations and joint clinical assessments under the EU Regulation on health technology assessment.
20 Jun 2025
Maya Matthews
Head of Unit
Discussion on the identification of clinical experts to participate in joint scientific consultations and joint clinical assessments under the EU Regulation on health technology assessment.SRC
28 May 2025
Laszlo Kristoffy
Cabinet member
Childhood cancerSRC
28 May 2025
Laszlo Kristoffy
Cabinet member
Childhood cancer
18 May 2021
Stella Kyriakides
Commissioner
Exchange of views on the implementation of Europe’s Beating Cancer Plan in paediatric oncologySRC
18 May 2021
Stella Kyriakides
Commissioner
Exchange of views on the implementation of Europe’s Beating Cancer Plan in paediatric oncology
09 Jun 2020
Mariya Gabriel
Commissioner
EU Paediatric Cancer Research agenda and how the European Paediatric Cancer Community could best partake in and support relevant initiatives
09 Jun 2020
Mariya Gabriel
Commissioner
EU Paediatric Cancer Research agenda and how the European Paediatric Cancer Community could best partake in and support relevant initiativesSRC
26 May 2020
Stella Kyriakides
Commissioner
VC meeting to discuss the EU's Cancer Plan and its objectives, cancer care and treatment during the COVID-19 pandemic
26 May 2020
Stella Kyriakides
Commissioner
VC meeting to discuss the EU's Cancer Plan and its objectives, cancer care and treatment during the COVID-19 pandemicSRC
21 Jan 2020
Tove Ernst
Cabinet member
Discussion on cancer
21 Jan 2020
Tove Ernst
Cabinet member
Discussion on cancerSRC
13 Dec 2018
Robert Schröder
Cabinet member
Health research and innovationSRC
13 Dec 2018
Robert Schröder
Cabinet member
Health research and innovation
19 Sept 2017
Marika Lautso-Mousnier
Cabinet member
Paediatric Regulation evaluation reportSRC
19 Sept 2017
Marika Lautso-Mousnier
Cabinet member
Paediatric Regulation evaluation report
12 Jun 2017
Annika Nowak
Cabinet member
Paediatric medicines
12 Jun 2017
Annika Nowak
Cabinet member
Paediatric medicinesSRC

Mission & Goals

The European Society for Paediatric Oncology (SIOP Europe, or SIOPE) is the single united European organization representing healthcare and research professionals in the field of childhood cancers, with over 2,700 members in 36 countries. The goal is to ensure the best possible care and outcomes for all children and young people with cancer in Europe. The objectives are to increase cure rates, enhance survivors’ quality of life, and tackle inequalities. Remit: - Research: e.g., serves as the common European platform for paediatric haemato-oncology clinical trials - Care: e.g., coordinates the development of European standards of care & fosters equal access - Education & Training: e.g., hub for learning & exchange on state-of-the-art science, clinical practice, and public policy - Advocacy: e.g., engages with the EU to foster an enabling policy environment for childhood cancer control SIOPE is also involved in the global health agenda via SIOP (international).

EU Legislative Interests

SIOPE focuses on policies and programmes addressing healthcare organization & delivery and health research, in particular in the areas of childhood cancer as well as cancer (overall) and rare diseases. Main EU initiatives followed as of October 2025: - Europe’s Beating Cancer Plan across its initiatives e.g. European Cancer Information Systems & Inequalities Registry - EU Cancer Mission - Pharmaceutical Strategy for Europe - Critical Medicine Act - EU Lifesciences Strategy - Heath Technology Assessment - European Reference Networks - Horizon Europe - EU4Health - Multi-annual Financial Framework - European Health Data Space - Health Emergency Preparedness and Response Main EU legislative files followed as of October 2025: - Revision of the EU Pharmaceutical Legislation including as pertaining to Regulation and Directive on Medicinal products for human use, Regulation on medicinal products for paediatric use, Regulation on orphan medicinal products, Regulation on advanced therapy medicinal products - Critical Medicines Act - Biotech Act - Innovation Act - MFF - General Data Protection Regulation [implementation and evaluations] - Directive on patients’ rights in cross-border healthcare [implementation and evaluations] - Clinical Trial Regulation [implementation and evaluations] SIOPE also follows EU initiatives in other relevant areas such as Employment, Social Affairs and Inclusion [e.g., European Pillar of Social Rights], International Partnerships [e.g., EU Global Health Strategy], Justice and Fundamental rights [e.g., EU Strategy on the Rights of the Child], Education, Youth, Sport and Culture [e.g. Erasmus+].

Communication Activities

PUBLICATIONS - SIOPE & CCI Europe European Elections Manifesto of the paediatric oncology and haematology community https://siope.eu/activities/european-advocacy/european-elections-manifesto-2024 - SIOPE Strategic Plan: A European Cancer Plan for Children and Adolescents & Update 2021-2026: https://siope.eu/european-strategic-plan/ - Vassal G et al. The SIOPE Strategic Plan: A European Cancer Plan for Children and Adolescents. Journal of Cancer Policy 2016. doi: 10.1016/j.jcpo.2016.03.007 - Vassal G et al. Challenges for children & adolescents with cancer in Europe: the SIOP-Europe agenda. PBC 2014. doi: 10.1002/pbc.25044 - Prades J et al. Do NCCPs address care & research for children, adolescents, and young adults? A review across 41 European countries. Lancet Oncol. 2025 Feb;49 doi:10.1016/j.lanepe.2024.101155 - Vassal G, Pearson ADJ. Cancer research in Europe: a focus on children and young people. Lancet Oncol 2023; 24: 8–9. - Kearns PR et al. European paediatric cancer mission: aspiration or reality? Lancet Oncol 2019. doi:10.1016/S1470-2045(19)30487-5 - Vassal G et al. Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children & adolescents. Lancet Child Adolesc Health 2023. doi: 10.1016/S2352-4642(22)00344-3 - Schoot RA et al. Market access to new anticancer medicines for children & adolescents with cancer in Europe. EJC 2022. doi:10.1016/j.ejca.2022.01.034 - Otth M et al. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE. Lancet Oncol 2022. doi: 10.1016/S1470-2045(22)00623-4 - Vassal G et al. Access to essential anticancer medicines for children & adolescents in Europe. Ann Oncol 2020. doi: 10.1016/j.annonc.2020.12.015 - Vassal G et al. The impact of the EU General Data Protection Regulation on childhood cancer research in Europe. Lancet Oncol 2022. doi: 010.1016/S1470-2045(22)00287-X - Otth M, de Rojas T, Rauwolf KK. Differences in care delivery for children & adolescents with cancer in Europe - Results from SIOPE OCEAN project. EJC PO 2025 June; 5 doi: 10.1016/j.ejcped.2025.100219 - SIOPE Organisation of Care & rEsearch for children with cANcer in Europe (OCEAN) project - Country profiles etc: https://siope.eu/activities/joint-projects/OCEAN - Otth M et al. The Healthcare Professionals’ and Patient Advocates’ Perspectives on Care for Children with Cancer in Europe-A Report from ESCALIER Project. Current Oncology 2025; 32(2): 84. doi: 10.3390/curroncol32020084 - Kowalczyk JR et al. Towards reducing inequalities: European Standards of Care for Children with Cancer. EJC 2014. doi: 10.1016/j.ejca.2013.11.004 - Janssens GO et al. The organization of care in pediatric radiotherapy across SIOP Europe affiliated centers: A multicenter survey in the framework of the 'Joint Action on Rare Cancers'. Radiother Oncol. 2024 doi: 10.1016/j.radonc.2023.110075 - Janssens GO et al. Recommendations for the organisation of care in paediatric radiation oncology across Europe: a SIOPE-ESTRO-PROS-CCI- Europe collaborative project in the framework of the JARC. EJC 2019. doi: 10.1016/j.ejca.2019.03.003 - Joint Action on Rare Cancers. Rare Cancer Agenda 2030: ten recommendations from the EU joint action. https://siope.eu/media/documents/rare- cancer-agenda-2030.pdf CAMPAIGNS - European Elections: Manifesto of the paediatric oncology and haematology community - Gold September-Childhood Cancer Awareness Month: wide engagement incl with MEPs - International Childhood Cancer Day: Annual policy event at European Parliament - Participation to EU World Cancer Day & European Week Against Cancer - Adolescent & Young Adults Cancer Week EVENTS incl - SIOPE ICCD annual event hosted by MEPs [topic 2025: “Cross-Border Access to Care, Research, and Training: Reducing Inequalities for Children with Cancer"] - SIOPE Annual Meeting [https://siopeurope.eu/]

Interests Represented

Does not represent commercial interests

Member Of

https://siope.eu/activities/partnerships/

Organisation Members

The SIOPE membership is based on the European National Paediatric Haemato-Oncology Societies or groups (‘NaPHOS’), which encourage their members to become part of the SIOPE network. In countries without NaPHOS, medical institutions and treatment centres specialised in paediatric cancer care can join SIOPE. Such centres can allow the paediatric haemato-oncology professionals in their institute to also become members of SIOPE. To ensure an open and continuously growing community, oncology professionals who are not members of a NaPHOS can also join SIOPE. List of members: https://siope.eu/about-siope/members/

Additional Information

The SIOPE accounts for 2024 are being finalized and information will be updated imminently.